Insulin resistance, another frequent metabolic abnormality in RA, compounds these effects by enhancing inflammatory and fibrotic responses through the activation of the receptor for advanced glycation end-products (RAGE) [15]. The gene discussed is AGER; the disease is rheumatoid arthritis.